“Final Report of a Phase II Trial of Nimotuzumab in the Treatment of Refractory and Relapsed High-Grade Gliomas in Children and Adolescents”. Hematology Meeting Reports 1, no. 6 (June 22, 2009). Accessed August 10, 2025. https://journals.pagepress.org/hmr/article/view/675.